Blue Earth Diagnostics and PETNET Solutions Inc Announce U.S. Commercial Availability of POSLUMA® for PET Imaging of Prostate Cancer

Blue Earth Diagnostics and PETNET Solutions Inc, A Siemens Healthineers Company have announced the commercial availability of POSLUMA® (flotufolastat F 18) in the United States. POSLUMA is an optimized, high-affinity radiohybrid (rh) Prostate-Specific Membrane Antigen (PSMA)-targeted PET imaging agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) p..